Coherent's 224Gbps TIA Launch: Product Innovation Fails to Address Core Investment Risks

What happened

Coherent announced the launch of its CHR1074 224Gbps quad-channel transimpedance amplifier, targeting next-generation 800G and 1.6T optical transceivers for AI and cloud infrastructure. This product release aligns with the company's strategic focus on its Datacenter and Communications segment, which is critical given recent expansions like the NVIDIA partnership and elevated market expectations. However, the DeepValue master report highlights that such announcements do not mitigate key concerns, including a lack of auditable shipment or backlog details from NVIDIA, as disclosed in filings. Inventories have surged to $1.848 billion as of December 2025, while operating cash flow weakened to $104 million over six months, signaling execution risks in converting capacity into cash. Investors should view this launch as a routine product update that does not alter the fundamental investment case without evidence of shipment growth or improved financial metrics.

Implication

The new TIA demonstrates Coherent's ongoing innovation in high-speed photonics, supporting its positioning as a key supplier in the AI datacenter ramp. However, it provides no new information on shipment volumes or backlog, which are essential for validating the multiyear NVIDIA purchase commitment highlighted in recent filings. Given the elevated inventory levels and weak cash conversion, success hinges on translating this product into actual sales without further working capital strain. Investors should closely monitor upcoming quarterly results, particularly sequential Datacenter and Communications revenue growth from $1.208 billion and inventory trends, for signs of shipment absorption. Until there is concrete evidence of improved cash flow and disclosed shipment details, the risk-reward profile remains unfavorable at current valuations of 44.44x EV/EBITDA.

Thesis delta

The product launch does not shift the investment thesis; it merely aligns with Coherent's existing growth narrative in AI optics without addressing the core risks of unverified NVIDIA commitments and financial strain. Investors should continue to adhere to the 'WAIT' rating, as tangible proof of shipment conversion and backlog disclosure remains absent.